[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ID25591A - META-AZASICLIC AMINO BENZOAT ACID COMPOUNDS AND ITS DECLARATION ARE INTEGRIN ANTAGONISTS - Google Patents

META-AZASICLIC AMINO BENZOAT ACID COMPOUNDS AND ITS DECLARATION ARE INTEGRIN ANTAGONISTS

Info

Publication number
ID25591A
ID25591A IDW20001695A ID20001695A ID25591A ID 25591 A ID25591 A ID 25591A ID W20001695 A IDW20001695 A ID W20001695A ID 20001695 A ID20001695 A ID 20001695A ID 25591 A ID25591 A ID 25591A
Authority
ID
Indonesia
Prior art keywords
azasiclic
benzoat
declaration
meta
amino
Prior art date
Application number
IDW20001695A
Other languages
Indonesian (id)
Inventor
Thomas E Rogers
Peter G Ruminski
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of ID25591A publication Critical patent/ID25591A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/12Nitrogen atoms not forming part of a nitro radical
    • C07D239/14Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IDW20001695A 1998-03-04 1999-02-22 META-AZASICLIC AMINO BENZOAT ACID COMPOUNDS AND ITS DECLARATION ARE INTEGRIN ANTAGONISTS ID25591A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3427098A 1998-03-04 1998-03-04

Publications (1)

Publication Number Publication Date
ID25591A true ID25591A (en) 2000-10-19

Family

ID=21875345

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001695A ID25591A (en) 1998-03-04 1999-02-22 META-AZASICLIC AMINO BENZOAT ACID COMPOUNDS AND ITS DECLARATION ARE INTEGRIN ANTAGONISTS

Country Status (29)

Country Link
EP (1) EP1060164A1 (en)
JP (1) JP2002505323A (en)
KR (1) KR20010041584A (en)
CN (1) CN1214011C (en)
AP (1) AP1244A (en)
AR (1) AR018139A1 (en)
AU (1) AU753230B2 (en)
BG (1) BG104740A (en)
BR (1) BR9908470A (en)
CA (1) CA2322207A1 (en)
EA (1) EA200000804A1 (en)
EE (1) EE200000506A (en)
GE (1) GEP20033118B (en)
HR (1) HRP20000574A2 (en)
HU (1) HUP0100865A3 (en)
ID (1) ID25591A (en)
IL (1) IL137653A0 (en)
IS (1) IS5582A (en)
MY (1) MY123908A (en)
NO (1) NO315703B1 (en)
NZ (1) NZ506598A (en)
OA (1) OA11530A (en)
PL (1) PL342726A1 (en)
SK (1) SK13002000A3 (en)
TR (1) TR200002542T2 (en)
UA (1) UA71906C2 (en)
WO (1) WO1999044994A1 (en)
YU (1) YU52000A (en)
ZA (1) ZA994406B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9805655D0 (en) 1998-03-16 1998-05-13 Celltech Therapeutics Ltd Chemical compounds
GB9814414D0 (en) 1998-07-03 1998-09-02 Celltech Therapeutics Ltd Chemical compounds
GB9821061D0 (en) 1998-09-28 1998-11-18 Celltech Therapeutics Ltd Chemical compounds
GB9826174D0 (en) 1998-11-30 1999-01-20 Celltech Therapeutics Ltd Chemical compounds
US6518283B1 (en) 1999-05-28 2003-02-11 Celltech R&D Limited Squaric acid derivatives
US6455539B2 (en) 1999-12-23 2002-09-24 Celltech R&D Limited Squaric acid derivates
DE60130910T2 (en) 2000-04-17 2008-07-10 Ucb Pharma, S.A. ENAMINE DERIVATIVES AS CELL ADHESION MOLECULES
US6545013B2 (en) 2000-05-30 2003-04-08 Celltech R&D Limited 2,7-naphthyridine derivatives
US6403608B1 (en) 2000-05-30 2002-06-11 Celltech R&D, Ltd. 3-Substituted isoquinolin-1-yl derivatives
US6921767B2 (en) * 2000-06-15 2005-07-26 Pharmacia Corporation Cycloalkyl alkanoic acids as integrin receptor antagonists derivatives
WO2002010136A1 (en) 2000-08-02 2002-02-07 Celltech R & D Limited 3-substituted isoquinolin-1-yl derivatives
MXPA05006732A (en) * 2002-12-20 2005-09-08 Pharmacia Corp The r-isomer of beta amino acid compounds as integrin receptor antagonists derivatives.
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
KR20080031266A (en) * 2005-06-10 2008-04-08 바이파 사이언스 인코포레이티드 Parp modulators and treatment of cancer
EP2131861A2 (en) 2007-03-01 2009-12-16 Mallinckrodt Inc. Integrated photoactive small molecules and uses thereof
JP4792124B1 (en) * 2010-11-15 2011-10-12 エフイートレード株式会社 Method for molding protective film for vehicle and method for manufacturing protective film for vehicle
CA2878469A1 (en) 2012-07-18 2014-01-23 Saint Louis University Beta amino acid derivatives as integrin antagonists
US8716226B2 (en) 2012-07-18 2014-05-06 Saint Louis University 3,5 phenyl-substituted beta amino acid derivatives as integrin antagonists
SG11201609050UA (en) 2014-05-30 2016-12-29 Pfizer Carbonitrile derivatives as selective androgen receptor modulators
EP3151670B1 (en) * 2014-06-04 2019-10-02 Monsanto Technology LLC 3,6-dichlorosalicylic acid compounds and related synthetic processes
CN108779077A (en) 2015-12-30 2018-11-09 圣路易斯大学 Meta position azacyclic amino benzoic acid derivatives as PAN integrin antagonists
MX2022014200A (en) 2020-05-14 2022-12-07 Ube Corp 1, 4, 5, 6-tetrahydropyrimidine-2-amine derivative.
WO2023275715A1 (en) 2021-06-30 2023-01-05 Pfizer Inc. Metabolites of selective androgen receptor modulators
EP4431098A1 (en) 2021-11-12 2024-09-18 UBE Corporation Pharmaceutical composition for providing treatment for or preventing alport syndrome

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11510814A (en) * 1995-08-30 1999-09-21 ジー.ディー.サール アンド カンパニー Meta-guanidine, urea, thiourea or azacyclic aminobenzoic acid derivatives as integrin antagonists

Also Published As

Publication number Publication date
PL342726A1 (en) 2001-07-02
CN1291978A (en) 2001-04-18
CN1214011C (en) 2005-08-10
CA2322207A1 (en) 1999-09-10
EA200000804A1 (en) 2001-04-23
BR9908470A (en) 2000-12-05
AR018139A1 (en) 2001-10-31
EP1060164A1 (en) 2000-12-20
AU753230B2 (en) 2002-10-10
AP1244A (en) 2004-02-04
BG104740A (en) 2001-02-28
YU52000A (en) 2003-02-28
GEP20033118B (en) 2003-11-25
EE200000506A (en) 2002-04-15
AP2000001893A0 (en) 2000-09-30
MY123908A (en) 2006-06-30
UA71906C2 (en) 2005-01-17
SK13002000A3 (en) 2001-07-10
NZ506598A (en) 2003-07-25
HUP0100865A2 (en) 2001-08-28
TR200002542T2 (en) 2001-05-21
IS5582A (en) 2000-08-04
AU3294799A (en) 1999-09-20
ZA994406B (en) 2000-02-11
IL137653A0 (en) 2001-10-31
KR20010041584A (en) 2001-05-25
NO20004316L (en) 2000-11-06
HRP20000574A2 (en) 2001-08-31
JP2002505323A (en) 2002-02-19
NO315703B1 (en) 2003-10-13
WO1999044994A1 (en) 1999-09-10
HUP0100865A3 (en) 2001-11-28
NO20004316D0 (en) 2000-08-30
OA11530A (en) 2004-05-17

Similar Documents

Publication Publication Date Title
ID25591A (en) META-AZASICLIC AMINO BENZOAT ACID COMPOUNDS AND ITS DECLARATION ARE INTEGRIN ANTAGONISTS
ID23953A (en) 5-ALKIL-2-ARILAMINOFENILASETAT ACID AND ITS DECLARATION
ID26773A (en) SUBSTITUTED SULFUR IN N-ARILAMIDA SULFONYLAMINCARCYLIC ACID, PREPARATION, USE AND PREPARATION FOR THE MAKING OF DRUGS WHICH INCLUDE IT
NO20026252D0 (en) AZA Bridge - Bicyclic amino acid derivatives as alpha 4 integrin antagonists
IS5744A (en) New 3-aryl-propionic acid derivatives and analogues
ID25651A (en) COMMITMENTS TO BISIKLO [2.2.1] RELATED HEPTINGS AND COMPOUNDS
ID21045A (en) MODIFIED AMINO ACID, THE DRUGS CONTAINING THIS COMPOUND AND THE PROCESS OF MAKING IT
ID26099A (en) AMIDA DEGREE AND NOSICEPTIN ANTAGONISTS
ID25861A (en) COMPOSITIONS OF PEST WASHER, THICKNESS, CLEANING AND ACID
ID22957A (en) COMPOUND AND ITS USE
ATE236146T1 (en) ALPHA-9 INTEGRIN ANTAGONISTS AND ANTI-INFLAMMATORY COMPOSITIONS CONTAINING THEM
ID28221A (en) BENZOTIEPIN WHICH HAS ACTIVITIES AS A RESILIENT OF ILEAL EMPEDU ACID TRANSPORT AND ABSORPTION OF TAUROCOLATE
ID23439A (en) 3-PIPERIDYL-4-OXSOKUINAZOLIN DECREASES AND THE SAME PHARMACY COMPOSITIONS
ID25543A (en) ALPHA-ARIL-N-ALKINITRON AND THE PHARMACY COMPOSITION CONTAINING IT
ID30322A (en) HETEROSICLIC CONTAINING aP2 BIFENIL INHIBITOR AND ITS METHODS
ID24686A (en) AMINO ACID BIOSINETIC PLANTS
IS5595A (en) Spraying of active substances
EE04440B1 (en) Capareceptor opioid peptides and a pharmaceutical composition
ID24654A (en) OMEPRAZOLA PHARMACEUTICAL FORMULATION
ID27887A (en) AEROSOL PHARMACEUTICAL FORMULATION
DE69823360D1 (en) SOLID MEDICAL CONSUMPTION CONTAINING BENZOFURANDERIVATE
PT864559E (en) SUBSTITUTED AMINO COMPOUNDS AND ITS USE AS ANALGESIC ACTIVE SUBSTANCES
ID26317A (en) EXTENDED FORMULATION
ID20134A (en) UREA SYNTHESIS AND IMPROVED UREA SYNTHESIS
IS5331A (en) New pharmaceutical mix